Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HLX03 vs Adalimumab in Moderate to Severe Plaque Psoriasis
NCT03316781Phase 3Completed
- Sponsor
- Henlius
- Start
- Oct 2017
- Primary completion
- Jul 2018
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of handayuan in plaque psoriasis, sponsored by Henlius. Started Oct 2017; status: completed.
02
Drugs
handayuan
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT03316781.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03316781.